Timely and effective implementation of evidence-based cardiovascular therapies for risk factor modification is making a favorable impact on vascular disease outcomes in patients with diabetes.
No takes yet. Share an insight, caveat, or question.
Prompts prompt therapy implementation in diabetes; leaves open optimal intervention targeting.
Beckman et al. (2013) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: